Explore Supplements Subscribe
The VerdictHIGH CONVICTIONVerdict Score 86

Hip arthritis responds better to targeted exercise than to injections — and most patients never get told this.

Summary: Hip osteoarthritis is often treated with rest and injections that studies now show don't work. The highest-quality medical guidelines have changed dramatically — exercise is now the #1 treatment, injections are out, and there's a whole subgroup of people (those with diabetes or metabolic is

  1. What the data actually shows: Exercise is the #1 treatment for hip arthritis — hyaluronic acid injections and ultrasound have been formally downgraded and are now recommended AGAINST by the highest-quality medical guidelines.
  2. What most people get wrong: If you have diabetes, are overweight, or have lost significant muscle mass, your hip OA is a different disease requiring a completely different approach — standard loading protocols won't work because they don't address the metabolic damage in your cartilage.
  3. Start here: Begin with bridges, clamshells, and slow sit-to-stands daily — pain during exercise should stay at 3/10 or below, and most people feel meaningful improvement within 4-6 weeks.

Think of your hip cartilage like a sponge that stays healthy only when you squeeze and release it rhythmically. When you stop moving — from pain or fear — the sponge dries out and stiffens. For people with diabetes or excess weight, the sponge's collagen fibers also get chemically glued together by sugar byproducts, making them brittle and prone to cracking. Exercise works on both problems: it resumes the squeeze-and-release cycle AND lowers the chemical signals that drive the gluing.

SH
Dr. Seth Holbrook, DPT — Doctor of Physical Therapy • Coach to 300+ clients
I built The Verdict to cut through recycled health advice and show what the evidence actually supports.
Physio Engine

Hip Osteoarthritis

Exercise Prescription — Body Region: Hip

HIGH Conviction RED Triage Hip
Scroll to explore

The Plain English Version

Hip arthritis responds better to targeted exercise than to injections — and most patients never get told this.

Think of your hip cartilage like a sponge that stays healthy only when you squeeze and release it rhythmically — that squeeze pumps in nutrients and pumps out waste. When you stop moving from pain or fear, the sponge dries out and stiffens. For people with diabetes or excess weight, the sponge's collagen fibers also get chemically glued together by sugar byproducts, making them brittle and prone to cracking. Exercise works on both problems: it restores the squeeze-and-release cycle, AND it lowers the biological signals that drive the gluing. Rest makes the first problem worse. Injections don't touch either one.

  1. What the data actually shows: Exercise is the #1 treatment for hip arthritis — hyaluronic acid injections and therapeutic ultrasound have been formally downgraded and are now recommended AGAINST by the highest-quality medical guidelines.
  2. What most people get wrong: If you have diabetes, are significantly overweight, or have lost muscle with age, your hip OA is a different disease requiring a different approach — standard loading won't work because it doesn't address the chemical damage to your cartilage.
  3. Start here: Begin with bridges, clamshells, and slow sit-to-stands daily — pain should stay at 3/10 or below during exercise, and most people feel meaningful improvement within 4–6 weeks.

Want the full evidence? Keep scrolling

What's Actually Going On

Two Diseases in One Label

Hip OA is a failure of the balance between cartilage breakdown and repair — but it fails through two distinct pathways that look similar on an X-ray and feel similar to the patient. Which pathway dominates changes everything about how you treat it.

Mechanical Pathway

Abnormal joint loading — from cam/pincer morphology, leg length discrepancy, or obesity — accelerates cartilage breakdown via mechanical stress on chondrocytes. Subchondral bone remodels, osteophytes form, joint space narrows.

Fix: Progressive loading, ROM restoration, weight management

Metabolic Pathway

Metabolic syndrome, Type 2 Diabetes, and obesity flood the joint with inflammatory signals (adipokines) that directly degrade cartilage — independent of mechanical load. Chronic high blood sugar generates AGEs that chemically cross-link cartilage collagen, making it brittle.

Fix: BFRT-first, protein optimization, glycemic management, GLP-1 referral

The AGE cross-linking mechanism: Advanced Glycation End-products form when sugar molecules bond to collagen fibers without enzymatic control. In articular cartilage, this makes the matrix dramatically stiffer and more susceptible to mechanical failure — explaining why metabolic OA patients get worse faster and respond differently to exercise.
Dark cinematic visualization of hip joint cartilage degeneration pathways

Key anatomy: articular cartilage (hyaline) covering femoral head and acetabulum; labrum deepening the joint; gluteus medius/minimus and hip flexors as dynamic stabilizers.

How to Identify It

Assessment & Diagnostic Tests

The classic presentation: "I have this deep ache in my groin, it's worse when I get up after sitting for a while, and I've been limping more lately."

ACR Diagnostic Cluster (rule-in): Hip/groin pain + passive IR <15° + flexion <115° + age >50 + morning stiffness <60 min. Two of three ROM criteria = hip OA until proven otherwise. Sn: 54% | Sp: 89%

Special Tests

FADIR Test Sn: 80–100% | Sp: 10–47%
Supine: hip to 90° flexion, adduct, internally rotate. Positive = groin/anterior hip pain. Rule-out test — high sensitivity, low specificity. Do NOT use in isolation.
FABER Test Sn: 41–82% | Sp: 17–25%
Supine: figure-4 position, allow knee to drop. Positive = groin/lateral hip pain. Useful for ruling out SI joint involvement when lateral pain dominates.
Passive Internal Rotation (neutral hip) Sn: 29% | Sp: 94%
Prone: neutral hip, measure passive IR. Reduced IR is the most specific single finding for structural OA — high specificity makes this a strong rule-in.
Trendelenburg Test
Single-leg stance: positive = contralateral pelvic drop, indicating gluteus medius weakness. Predicts functional impairment and guides rehab priorities.
Dark cinematic visualization of hip assessment and physical examination

Differential Diagnosis

Dark cinematic visualization comparing hip pathologies
Condition Key Differentiator Rule-Out Test
GTPS / Gluteal Tendinopathy Lateral hip dominant; groin pain absent; no restricted IR Greater trochanter palpation tender; FABER provokes lateral, not groin pain
Lumbar Referred Pain (L3/L4) Anterior thigh pain + lumbar signs; hip ROM full Lumbar quadrant test positive; hip ROM full and pain-free
Labral Tear Younger patient; clicking/locking; activity-related; C-sign MRI arthrogram; FADIR in younger active patient without K-L grade 3+
Avascular Necrosis (AVN) Progressive severe pain + corticosteroid/alcohol/cancer history; night pain Urgent MRI — X-ray may be normal early
Inflammatory Arthritis (RA/SpA) Morning stiffness >60 min; bilateral; systemically unwell; younger onset ESR, CRP, RF, HLA-B27; rheumatology referral
Femoral Neck Stress Fracture Athlete + anterior hip/groin pain + weight-bearing pain; no ROM restriction Urgent MRI

When to Refer

Red Flags — Do Not Miss These

Dark cinematic visualization of urgent hip pathology signs

⚠ Refer Immediately

  • Progressive severe pain + night pain + history of corticosteroids, alcohol use, cancer, radiation — suspect Avascular Necrosis (AVN). X-ray may be normal early.
    Urgent MRI
  • Known cancer history + new hip pain — bone metastasis or radiation-induced AVN.
    Oncology
  • Fever, systemically unwell, joint hot + swollen — septic arthritis.
    A&E Immediately
  • Morning stiffness >60 minutes + bilateral involvement + systemically unwell — inflammatory arthritis (RA/SpA).
    Rheumatology
  • New-onset severe limp without trauma in young patient — stress fracture or AVN.
    Urgent MRI
  • No symptom improvement despite objective strength and neuromuscular gains after 4–8 weeks of targeted PT — failure of conservative trial.
    Orthopaedic Hip Specialist

The Debate

CPG vs Recent Evidence

Therapeutic Ultrasound

APTA CPG, 2017
Therapeutic ultrasound recommended for short-term pain relief in hip OA.
→
APTA CPG, 2025
Downgraded to Grade D "Do Not Use". Sham-controlled RCTs show no benefit over placebo.
Clinical implication: Remove therapeutic ultrasound from all hip OA protocols. Including it wastes clinical time and patient money with no evidence base.

Hyaluronic Acid Injections

Historical Practice
Viscosupplementation variably used as first-line injection option for hip OA pain.
→
AAOS CPG, 2023
Strong Recommendation AGAINST. Meta-analyses consistently show no improvement in pain or function vs. placebo.
Clinical implication: Do not recommend. Counsel patients against spending money on this. It is not a bridge to exercise — it is not a bridge to anything.

Manual Therapy Dosing

APTA CPG, 2017
General mobilization Grade A for hip OA.
→
APTA CPG, 2025
Grade A now expanded to include high-force long-axis distraction specifically for ROM improvement — distinct mechanism from low-force.
Clinical implication: Apply both strategically — low-force distraction for pain-dominant presentations, high-force for ROM-dominant cases. They are complementary, not interchangeable.

Real World vs Lab

Translational Limitations

The Placebo Problem

Research Lab Sham physical therapy and sham ultrasound produced 21–23 point improvements in pain/function scores — often matching active intervention groups.
Real World Gap Effect sizes for specific modalities may be substantially smaller than published data suggests. Therapeutic alliance accounts for a large proportion of OA treatment response.
Adjust Expectations

Clinical adjustment: Lean into the therapeutic relationship and patient education as active ingredients. Time spent explaining OA biology IS the intervention.

Supervised Protocol vs Home Reality

Research Lab GLA:D (6-week supervised, 2-3x/week) shows excellent pain and function outcomes with high exercise fidelity.
Real World Gap Real-world adherence drops to 40–60% at 6 months post-discharge. Translating 1-5 sessions/week for 16 weeks into sustained home compliance is a significant barrier.
Scale Down

Clinical adjustment: Build home exercise programs around 3 high-yield exercises maximum. Use behavioral strategies (habit stacking, symptom tracking). Check compliance explicitly at every session.

Metabolic Phenotype Under-Recognition

Research Lab Metabolic OA has fundamentally different pathophysiology — BFRT-first, protein optimization, glycemic management — shown in RCTs.
Real World Gap Standard hip OA patients are treated with mechanical loading protocols without metabolic screening. This subgroup progresses to surgery faster.
Screen First

Clinical adjustment: Screen every hip OA patient for T2DM, metabolic syndrome, and muscle loss at first assessment. If metabolic phenotype present, restructure entire rehab before loading progressions.

What Works

Treatment Hierarchy

Dark cinematic visualization of hip rehabilitation and exercise therapy

Tier 1 — Strong Evidence

1

Individualized Progressive Exercise Therapy HIGH

Hip-specific strengthening (abductors, extensors, flexors) + neuromuscular training + functional tasks. 1–5 sessions/week, 30–120 min/session, 5–16 weeks.

Pain reduction: 4–6 weeks | Functional improvement: 8–12 weeks | Full program: 16 weeks

APTA CPG 2025 — Grade A

2

GLA:D Program HIGH

Structured 6-week neuromuscular training protocol with patient education. 2-3x/week, 12 supervised sessions. Validated across multiple countries.

Meaningful improvements: 3 months | Maintained at: 12 months (adherent patients)
3

Manual Therapy — Low-Force Long-Axis Distraction HIGH

Sustained long-axis distraction techniques to the hip. Grade A for pain reduction. Combine with exercise for best outcomes.

Immediate pain modulation | 4–6 sessions for cumulative ROM benefit

APTA CPG 2025 — Grade A

4

Manual Therapy — High-Force Long-Axis Distraction HIGH

Grade V manipulation-grade distraction. Grade A specifically for ROM improvement. Apply when ROM is the primary limiter.

ROM improvements: 2–4 sessions

APTA CPG 2025 — Grade A

5

Weight Management (5–7.5% body weight for BMI >25) HIGH

Dietary + activity intervention targeting systemic inflammation. Reduces adipokines, offloads joint mechanically, delays surgery.

Symptom benefit begins with 5% reduction | Structural benefits require sustained loss
6

Short-Term NSAIDs HIGH

For acute pain management to enable exercise participation. Not for long-term use. Use as a bridge to get the patient moving, not to avoid moving.

Pain relief: 24–48 hours

AAOS/AAFP — Grade A

See full treatment hierarchy (Tier 2 & 3)

Tier 2 — Moderate Evidence

7

Blood Flow Restriction Training (BFRT) MODERATE

Low-load resistance training (20–40% 1RM) with vascular occlusion cuff (50–80% AOP). First-line for metabolic phenotype and patients with muscle loss. Protocol: 4 sets — 30-15-15-15 reps, 30–60s rest, 2–4x/week.

Hypertrophy + strength comparable to 70–80% 1RM: 6–8 weeks | Joint stress minimized
8

Aquatic Therapy / Hydrotherapy MODERATE

Warm-water exercise reducing joint load via buoyancy. Useful bridge when land-based loading is too painful. Transition to land-based as tolerated.

Grade A (APTA 2025) | Wide dosing range: 30–120 min, 1–5x/wk
9

Intra-Articular Corticosteroids MODERATE

Short-term pain relief to enable exercise. Maximum 3 injections/year — risk of rapidly progressing arthritis with repeated use. Always gate with exercise follow-up appointment.

Pain benefit: 1–2 weeks | Up to 4 months

Tier 3 — Emerging / Clinical Experience

10

Protein Supplementation for Metabolic OA EMERGING

1.5 g/kg/day total protein; 25–30g high-quality protein (whey/casein/leucine-rich) twice daily on training days. Essential adjunct for metabolic phenotype — exercise alone insufficient for muscle loss OA.

11

GLP-1 Agonists (via GP/physician referral) EMERGING

Weight reduction + anti-inflammatory effect for metabolic phenotype. Indirect evidence via metabolic pathway — no OA-specific RCTs yet. Flag for GP referral in appropriate patients.

What Doesn't Work

  • Therapeutic Ultrasound — Downgraded to Grade D "Do Not Use" (APTA 2025). Sham-controlled RCTs show zero benefit over placebo. Remove from all protocols.
  • Hyaluronic Acid (viscosupplementation) — Strong Recommendation AGAINST (AAOS 2023). Meta-analyses show no improvement in pain or function vs. placebo despite widespread historical use.
  • Oral Opioids for nonoperative OA — Strong Recommendation AGAINST (AAOS 2023). Safety risks without superior long-term efficacy. Escalate to surgical referral before opioids.
  • PRP (Platelet-Rich Plasma) — Insufficient evidence (AAOS 2023/2025). No clinically significant benefit over placebo at 12-month follow-up.
  • Passive modalities alone (TENS, heat, massage) as primary treatment — Acceptable pain management adjuncts only when enabling exercise. Zero evidence for standalone structural change.

Exercise Prescription

Patient Action Plan

Pain guide: 0–3/10 during exercise = acceptable. 3–5/10 = reduce load. >5/10 = stop and modify. Pain 24h after exercise should be 0–2/10.

Hip Bridges

3 × 12 | Daily

Lie on back, knees bent, feet flat. Push hips toward ceiling, squeeze glutes, hold 2 seconds, lower down.

Feel it: glutes and back of thigh — no sharp groin pain

Clamshells

3 × 15 each side | Daily

Lie on side, knees bent in stack, feet together. Open top knee like a clamshell, hold 2 seconds, close. Pelvis still.

Burn in outer hip = normal. Stop if groin pain starts.

Slow Sit-to-Stand

3 × 10 | Daily

Arms crossed on chest. Stand up over 3 seconds, pause, sit down over 3 seconds. Use hands only if needed.

Mild hip discomfort = ok. Sharp pain = stop and reduce depth.

Standing Hip Abduction

2 × 12 each side | 3x/week

Hold wall for balance. Light resistance band above ankles. Move one leg out to side 12 inches, hold, return.

Feel it: outer hip/buttock — not the groin.

Stationary Cycling (warm-up)

10 min | Every session

Comfortable pace, steady movement. Sets up joint nutrition before resistance work.

"Somewhat hard" — should be able to hold a short conversation.

Progression Timeline

Weeks 1–2: Focus on movement patterns. Slow and controlled. Pain ≤3/10 only.

Weeks 3–4: Add light resistance bands to bridges and clamshells. Start hip abduction exercise. Increase sit-to-stand reps.

Weeks 5–8: Single-leg bridges (if bilateral pain-free). Add gentle walking 10–20 min. Increase band tension when 3×15 feels easy.

Weeks 9+: Introduce lateral lunges and step-ups once single-leg bridges and sit-to-stand are pain-free. Walking 20–30 min daily.

Metabolic Phenotype (T2DM / significant excess weight / muscle loss): Start with BFRT — 20–40% 1RM, 4 sets (30-15-15-15 reps), 30–60s rest, 2–4x/week at 50–80% arterial occlusion pressure. Add 1.5g/kg/day protein target. Flag GP for glycemic management and GLP-1 consideration before standard loading progressions.

Return to Training

Criteria Before Returning to Full Load

Load management: Stop heavy barbell squats, deadlifts, running, plyometrics immediately. Switch to machines/cables (hack squat, leg press) with reduced ROM. Pool or cycling for cardio. Continue: walking at comfortable pace, upper body training.

The Nuance

Surgery vs Conservative — The Honest Truth

Dark cinematic visualization of hip joint and surgical considerations

Conservative Management

  • Best for K-L grade 1-2 with intact functional goals
  • Patient not yet medically optimized for surgery (BMI, glycemic control, cardiovascular status)
  • Significant muscle loss — prehabilitation optimizes post-op outcomes if surgery becomes necessary
  • Patient preference with willingness to engage in supervised exercise
  • Meaningful pain + function improvement in 4–6 weeks for most patients with good-quality PT

Surgical Referral (THA)

  • Failure of 4–8 weeks targeted, supervised PT with documented objective strength gains but NO symptom improvement
  • End-stage radiographic progression: K-L grade 3-4, subchondral collapse, AVN with severe functional limitation
  • Unacceptable quality-of-life impact despite maximal conservative management
  • Rapidly progressing structural disease with severe mechanical symptoms
  • THA: 85–95% patient satisfaction, return to recreation 6–12 months

The honest truth: Exercise therapy works well for hip OA, but it doesn't stop disease progression — it manages it. The goal is to optimize pain, function, and quality of life, delay surgery as long as function is acceptable, and ensure patients go into surgery as strong and fit as possible. THA is not a failure — it's an excellent outcome when the timing is right. The mistake is waiting too long and operating on a severely deconditioned patient.

Common Misconceptions

"You should rest to avoid making it worse." — The opposite is true. Disuse atrophies the muscles that protect the joint and allows cartilage to dry out from lack of loading. Movement is the treatment.

"Hyaluronic acid lubricates the joint." — This is the most persistent myth in hip OA management. It has been formally disproven in large meta-analyses. The joint fluid of OA patients is not deficient in viscosity in a way that injections can correct at meaningful clinical scale.

"If I have OA I'll definitely need a hip replacement." — A clinically meaningful proportion of K-L grade 1-2 patients achieve lasting pain and function improvements with supervised exercise therapy and never require surgery. The goal is optimal management, not inevitable surgery.

86.7% risk: After a unilateral total hip arthroplasty, the contralateral hip has an 86.7% risk of developing radiographic OA over follow-up. Metabolic management and exercise are the most effective tools for delaying bilateral disease.

Sources

Key References

2025
APTA Clinical Practice Guideline — Hip OA

Individualized exercise Grade A (1-5x/wk, 30-120 min, 5-16 wks); manual therapy Grade A; therapeutic ultrasound downgraded to Grade D "Do Not Use"

2023
AAOS Clinical Practice Guideline

Strong recommendation AGAINST hyaluronic acid and oral opioids for nonoperative hip OA. PRP evidence insufficient. Weight management Grade A.

Ongoing
GLA:D Program (Good Life with osteoArthritis in Denmark)

6-week neuromuscular training protocol (12 supervised sessions, 2-3x/week). Validated across multiple countries with sustained outcomes at 12 months.

ACR
ACR Clinical Classification Criteria for Hip OA

Pain + IR <15° + Flexion <115° cluster: Sn 54%, Sp 89%. FADIR: Sn 80-100%, Sp 10-47%.

2026
Gemini Deep Research

AGE cross-linking mechanism in metabolic OA phenotype; BFRT 20-40% 1RM 30-15-15-15 protocol; protein 1.5g/kg/day for muscle loss OA; 86.7% contralateral OA risk post-unilateral THA; surgical referral criterion validation.

2025
AAOS / Wellmark Review — PRP for Hip OA

No clinically significant benefit over placebo at 12-month follow-up. Some trials show PRP > hyaluronic acid but not > placebo or corticosteroids at 12 months.

HIGH CONVICTION

What would change this protocol: Emergence of a disease-modifying drug (DMOAD) that reliably reverses cartilage loss; new RCT data showing specific exercise modalities outperform individualized progressive loading at Grade A level.

Physio Engine| Conditions completed: 32 | 2026-03-23

Verdict Score

How strong is the evidence for the claims in this review? Higher = more confidence the claims are supported. This does not measure how large the effect is or how important it is compared with other levers.

86 Strong evidence
80–100Strong evidence ◀
60–79Mixed but supportive
40–59Uncertain
0–39Weak support

Get weekly evidence-based rehab verdicts

Physio conditions reviewed against clinical evidence. What works, what doesn't, and what to do — from a practising physiotherapist.

Subscribe free

Want a coach, not just research?

The Verdict is built by the same team behind Precision Metrics — a physique and health coaching practice with 300+ clients coached. Dr. Seth Holbrook, DPT and Luke Holbrook lead the coaching.

Book a free consultation

Related free research

Pain & Rehab
Baxter's Nerve Entrapment — The Verdict
 Pain & Rehab
Heel Fat Pad Syndrome — The Verdict
 Pain & Rehab
Flexor Hallucis Longus Tendinopathy ("Dancer's Tendinitis") — The Verdict

There are 424 more inside

Conviction-scored verdicts on supplements, nutrition, training, physio, and recovery.

Explore all Get weekly verdicts